Frontlight ResearchEarly access
CompletedNo phase
Concept Elicitation and Patient Experience Mapping in SA-AKI
Key facts
- Who runs it
- Novartis Pharmaceuticals
- Where
- East Hanover, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 28 people enrolled
- Started
- 1 May 2025
- Ended
- 30 Sept 2025
- Type of study
- Observational
- Record updated
- 12 December 2025
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Potential participants who were diagnosed with SA-AKI (KDIGO stage I, II or III) must meet the following eligibility criteria:
- ≥18 to ≤ 85 years of age
- First diagnosis of SA-AKI at least 6 months prior to screening date, but no more than 10 years
- Admitted due to sepsis and/or AKI to intensive care unit (ICU), intermediate care unit (IMCU), or high-dependency care unit, or developed sepsis and/or AKI during their inpatient hospital stay
- Resident of country of study (US or Germany)
- Access to computer, tablet, or smartphone with internet connection
- Willing to participate in an audio recorded interview; Participants will be required to present confirmation of diagnosis (COD) rather than relying on a self-reported diagnosis. Sepsis and AKI diagnoses will be confirmed through one of the following:
- Copy of medical records (e.g., portable document format [PDF] file of electronic health record)
- Physician confirmation of diagnosis of sepsis and AKI (post-sepsis); Potential caregiver participants must meet the following criteria:
- ≥18 to ≤ 85 years of age
- Primary caregiver/care-partner for eligible participant who experienced SA-AKI
- Resident of country of study (US or Germany)
- Access to computer, tablet, or smartphone with internet connection
- Willing to participate in an audio recorded interview
Who cannot take part
- Less than age of majority in locality (Participant is not considered an adult in their country or region)
- Potential participants are not eligible if they meet any of the following criteria:
- Not willing to participate in an audio recorded interview
- Not able to participate in the interview or complete required study surveys, based on the discretion of the study team
Where in United States
- East Hanover, New JerseyHospital not named in the registry
About the trial
What the trial wants to find out
This is a concept elicitation study on patient's experiences of Sepsis-associated Acute Kidney Injury (SA-AKI)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Concept Elicitation and Patient Experience Mapping in Sepsis-associated Acute Kidney Injury
- Record updated
- 12 December 2025